Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease (Q47352480)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 January 2017
edit
Language Label Description Also known as
English
Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease
scientific article published on 18 January 2017

    Statements

    Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit